DUXA
Double homeobox protein A
Also known as: DUXA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NLW8
- Gene
- DUXA
- Ensembl
- ENSG00000258873
- Chromosome
- 19
- Canonical length
- 204 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Homeobox genes encode DNA-binding proteins, many of which are thought to be involved in early embryonic development. Homeobox genes encode a DNA-binding domain of 60 to 63 amino acids referred to as the homeodomain. This gene is a member of the DUXA homeobox gene family. Evidence of mRNA expression has not yet been found for this gene. Multiple, related processed pseudogenes have been found which are thought to reflect expression of this gene in the germ line or embryonic cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
204 residues, UniProt reviewed canonical sequence.
>A6NLW8|DUXA
1 MAEDTYSHKM VKTNHRRCRT KFTEEQLKIL INTFNQKPYP GYATKQKLAL EINTEESRIQ
61 IWFQNRRARH GFQKRPEAET LESSQSQGQD QPGVEFQSRE ARRCRTTYSA SQLHTLIKAF
121 MKNPYPGIDS REELAKEIGV PESRVQIWFQ NRRSRLLLQR KREPVASLEQ EEQGKIPEGL
181 QGAEDTQNGT NFTSDSHFSG ARTWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUXA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 0.2 nTPM
- adipose tissue: 0.1 nTPM
- appendix: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- duodenum: 0.1 nTPM
- endometrium: 0.1 nTPM
Single-cell type
- late spermatids: 1.6 nCPM
- sertoli cells: 1.1 nCPM
- neuroendocrine cells: 0.8 nCPM
- vascular smooth muscle cells: 0.6 nCPM
- undifferentiated spermatogonia: 0.4 nCPM
- cardiomyocytes: 0.3 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 1.6 nTPM
- hypothalamus: 1.6 nTPM
- thalamus: 1.5 nTPM
- white matter: 1.5 nTPM
- basal ganglia: 1.4 nTPM
- cerebellum: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.51
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.02
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUXA as an antibody target. Whether an autoantibody or antibody against DUXA could matter depends on whether native DUXA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUXA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUXA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...